Incannex Healthcare (IXHL) News Today → Write this ticker symbol down… (From StocksToTrade) (Ad) Free IXHL Stock Alerts $3.25 +0.05 (+1.56%) (As of 06/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest UpdateIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) saw a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 44,700 shares, a decrease of 18.6% from the April 30th total of 54,900 shares. Currently, 0.4% of the company's stock are short sold. Based on an average daily volume of 290,200 shares, the short-interest ratio is presently 0.2 days.May 30, 2024 | globenewswire.comPatient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep ApneaMay 15, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 31.3% in AprilIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 54,900 shares, an increase of 31.3% from the April 15th total of 41,800 shares. Based on an average daily volume of 306,200 shares, the short-interest ratio is presently 0.2 days. Currently, 0.5% of the company's shares are sold short.May 7, 2024 | finanznachrichten.deIncannex Healthcare: Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderMay 7, 2024 | globenewswire.comIncannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderMarch 29, 2024 | msn.comPsyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's InfluenceMarch 28, 2024 | marketbeat.comShort Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Grows By 113.1%Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 208,200 shares, a growth of 113.1% from the February 29th total of 97,700 shares. Based on an average daily trading volume, of 309,800 shares, the short-interest ratio is presently 0.7 days. Approximately 1.8% of the company's shares are short sold.March 24, 2024 | morningstar.comIncannex Healthcare Inc IXHLMarch 22, 2024 | msn.comPsychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In ColoradoMarch 19, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 03:03 PM with a stated reason of "LULD pause." Trading set to resume at 04:03 PM. March 3, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 57.3% in FebruaryIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 97,200 shares, an increase of 57.3% from the January 31st total of 61,800 shares. Based on an average trading volume of 94,300 shares, the short-interest ratio is presently 1.0 days. Approximately 0.6% of the company's shares are sold short.February 28, 2024 | markets.businessinsider.comIncannex's Phase 2 Psi-GAD1 Trial Of Psilocybin Meets Primary Endpoint; Stock Surges 39%February 28, 2024 | msn.comNovavax, Applied Therapeutics, Incannex among healthcare moversFebruary 28, 2024 | finance.yahoo.comIncannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety DisorderFebruary 28, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 09:02 AM with a stated reason of "LULD pause."February 28, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM. February 21, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:02 PM with a stated reason of "LULD pause."February 21, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:02 PM with a stated reason of "LULD pause." Trading set to resume at 12:02 PM. February 16, 2024 | finanznachrichten.deIncannex Healthcare: Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking CessationFebruary 16, 2024 | finance.yahoo.comIncannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking CessationFebruary 16, 2024 | globenewswire.comIncannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking CessationFebruary 4, 2024 | finance.yahoo.comWe're Keeping An Eye On Incannex Healthcare's (NASDAQ:IXHL) Cash Burn RateFebruary 1, 2024 | proactiveinvestors.comIncannex Healthcare begins dosing in Phase 2 clinical trial...February 1, 2024 | finance.yahoo.comClarion Clinics Open for Psychedelic-Assisted TreatmentsJanuary 25, 2024 | msn.comPodcast: International Cannabis And Psychedelics Co. Is Working 'Hand In Hand' With FDA To Forge New Therapy FrontiersJanuary 24, 2024 | finance.yahoo.comIncannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid ArthritisJanuary 18, 2024 | finance.yahoo.comIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis CommencesJanuary 17, 2024 | finance.yahoo.comIncannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep ApneaJanuary 14, 2024 | seekingalpha.comIXHL Incannex Healthcare Inc.January 12, 2024 | marketbeat.comShort Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Grows By 107.5%Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totalling 93,600 shares, a growth of 107.5% from the December 15th total of 45,100 shares. Based on an average daily volume of 65,000 shares, the short-interest ratio is currently 1.4 days. Currently, 0.0% of the shares of the stock are short sold.December 28, 2023 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Increase in Short InterestIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 45,100 shares, an increase of 705.4% from the November 30th total of 5,600 shares. Based on an average trading volume of 62,900 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.0% of the shares of the stock are short sold.December 27, 2023 | msn.comPsyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & MoreDecember 24, 2023 | benzinga.comIncannex Healthcare Stock (NASDAQ:IXHL) Dividends: History, Yield and DatesDecember 23, 2023 | msn.comIncannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In AustraliaDecember 20, 2023 | marketbeat.com5 Biotech stocks tapping into unmet mental health treatment needs (IXHL)Here are five biotech companies currently working on drug candidates that tap into this soaring need for life-saving mental health treatments.December 6, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 10:12 AM with a stated reason of "LULD pause."December 6, 2023 | finance.yahoo.comIncannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep ApneaDecember 5, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 10:12 AM with a stated reason of "LULD pause."December 5, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 10:12 AM with a stated reason of "LULD pause."December 5, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 10:12 AM with a stated reason of "LULD pause."December 4, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:12 PM with a stated reason of "LULD pause."December 4, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:12 PM with a stated reason of "LULD pause."December 4, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:12 PM with a stated reason of "LULD pause."December 4, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:12 PM with a stated reason of "LULD pause."November 30, 2023 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 1.47%November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 03:11 PM with a stated reason of "LULD pause." Trading set to resume at 04:11 PM. November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 02:11 PM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 02:11 PM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 02:11 PM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "IXHL" at 02:11 PM with a stated reason of "LULD pause." Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him IXHL Media Mentions By Week IXHL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IXHL News Sentiment▼0.000.76▲Average Medical News Sentiment IXHL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IXHL Articles This Week▼02▲IXHL Articles Average Week Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aurinia Pharmaceuticals News Pliant Therapeutics News Longboard Pharmaceuticals News Phibro Animal Health News Nuvation Bio News Olema Pharmaceuticals News AnaptysBio News Mineralys Therapeutics News Sage Therapeutics News Dianthus Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IXHL) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companie...Banyan Hill Publishing | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored